Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 33 clinical trials
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).

Children's National Medical Center
 (5.4 away) Contact site
  • 46 views
  • 08 Nov, 2020
  • +8 other locations
PRISM Study-Pruritus Relief Through Itch Scratch Modulation

To investigate the anti-pruritic efficacy and safety of Nalbuphine ER (NAL ER) tablets in Prurigo Nodularis. Subjects will be randomized to NAL ER (or matching placebo) with the primary endpoint evaluation at Week 14. During the open label extension, subjects who received NAL ER will continue on NAL ER and …

nalbuphine
Study Site 128
 (7.0 away) Contact site
  • 661 views
  • 01 Oct, 2020
  • +75 other locations
A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

The main purpose of this study is to measure the amount of lopinavir/ritonavir (two anti-HIV medications) in the blood. Results from this study will be compared to the levels of the drugs that have been found in other studies that showed that these medications were safe and effective.

lopinavir/ritonavir
lopinavir
kaletra
ritonavir
HIV Vaccine
Howard University Washington, DC NICHD CRS (5044)
 (5.1 away) Contact site
  • 340 views
  • 08 Nov, 2020
  • +55 other locations
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

This study aims to evaluate the safety, tolerability and efficacy of molnupiravir (MK-4482) compared to placebo. The primary hypothesis is that molnupiravir is superior to placebo as assessed by the percentage of participants who are hospitalized and/or die through Day 29

Emerson Clinical Research Institute ( Site 1828)
 (4.4 away) Contact site
  • 0 views
  • 25 Nov, 2020
  • +24 other locations
A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children

The purpose of this study is to evaluate the safety and tolerability of MEDI8897 compared to palivizumab when administered to preterm infants entering their first RSV season and children with chronic lung disease (CLD) and congenital heart disease (CHD) entering their first and second RSV season.

chronic disease
bronchodilator
palivizumab
diuretics
Research Site
 (5.8 away) Contact site
  • 475 views
  • 25 Nov, 2020
  • +338 other locations
Investigational Therapeutics for the Treatment of People With Ebola Virus Disease

Background Ebola virus can cause serious illness or death. No medicines are approved to treat it. Researchers need to test new medicines to see if they help people recover from Ebola and are safe to give. They need to test the drugs and compare them in a controlled way. Researchers …

National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 8 views
  • 12 Aug, 2019
  • +1 other locations
Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck

The goal of this clinical research study is to compare the side effects of 2 radiation treatments for head and neck cancer. The 2 treatments are intensity modulated photon therapy (IMRT) and intensity modulated proton therapy (IMPT). Participants will also receive chemotherapy along with radiation therapy. IMPT is designed to …

x-rays
metastasis
concurrent chemotherapy
carcinoma
oropharyngeal
University of Maryland
 (2.8 away) Contact site
  • 41 views
  • 08 Oct, 2020
  • +10 other locations
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

This study will evaluate the safety and effectiveness of the investigational drug DDP733 in treating female patients with IBS-c. A placebo control will be utilized.

abdominal pain
discomfort
constipation
Metropolitan Gastroenterology Group, PC Chevy Chase Clinical Research
 (8.1 away) Contact site
  • 5594 views
  • 07 Nov, 2020
  • +67 other locations
Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery

Many types of cancer are primarily treated with surgery and patient survival is directly related to the extent to which the tumor is able to be removed. It is often difficult for surgeons to distinguish tumor tissue from normal tissue or to detect tumor cells that have spread from the …

Children's National Medical Center
 (5.4 away) Contact site
  • 0 views
  • 01 Nov, 2020
  • +9 other locations
A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

This is a Phase 2/3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002) given monthly for 6 doses in adult and adolescent patients with active eosinophilic esophagitis. Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of …

eosinophil count
eosinophilia
ak002
hysterectomy
dysphagia
Allakos Investigational Site
 (7.8 away) Contact site
  • 115 views
  • 25 Nov, 2020
  • +57 other locations